Therapeutics
J&J to buy Halda Therapeutics in US$3.05 billion cash deal
[ad_1] [NEW YORK] Johnson & Johnson has agreed to buy the cancer treatment biotech Halda Therapeutics for US$3.05 billion cash, part of a strategy to cope with eroding sales for...
Lightstone Ventures, Temasek’s ClavystBio co-lead Allay Therapeutics’ US$57.5 million Series D funding
[ad_1] The company’s technology is used to create analgesic products that can aid patients with post-surgical pain management and recuperation[SINGAPORE] United States-based biotechnology company Allay Therapeutics on Thursday (Jun 5)...